BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
BillionToOne, Inc.NASDAQ: BLLN
Total Assets · Q2 FY2026 · quarter ended Jun 2026
Total assets rises 133.4% from a year ago
Total assets stood at $729.7M at the end of Q2 FY2026, up 133.4% from a year earlier and up 4.1% from the prior quarter.
Context
- Total assets increased in 2 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether total assets keeps rising in the next quarterly balance sheet after a +133.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
USD · from the balance sheet
- Latest · FY2025
- 632.65M USD
- Year-over-year change
- +109.4%
- 2-year CAGR
- +81.7%
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 632.65M | +109.4% |
| FY2024 | 2024-12-31 | 302.06M | +57.6% |
| FY2023 | 2023-12-31 | 191.68M | — |
Total Assets vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's Jun 2026 total assets of $729.7M is the 7th highest of the 9 companies compared; the peer median is $1.42B.
- Its year-over-year change of +133.4% is the highest of 9, against a peer median of +4.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Jun 2026 | $2.84B | +5.2% | -19.5% | |
| Jun 2026 | $2.66B | +51.2% | +21.6% | |
| Sep 2026 | $1.89B | +47.7% | +7.7% | |
| Jun 2026 | $1.49B | +10.6% | +6.7% | |
| Jun 2026 | $1.35B | -3.0% | -7.9% | |
| Mar 2026 | $1.16B | -4.1% | -4.3% | |
BLLNBillionToOne, Inc. | Jun 2026 | $729.7M | +133.4% | — |
| Mar 2026 | $673.7M | -33.0% | -16.2% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $481.49M | +3.8% | +1.5% |
| Peer median (excluding BLLN) | $1.42B | +4.5% | -1.4% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.